Mark Chen
Publications by Year
Research Areas
Neurofibromatosis and Schwannoma Cases, Sarcoma Diagnosis and Treatment, Bone Tumor Diagnosis and Treatments, Neuroblastoma Research and Treatments, CAR-T cell therapy research
Most-Cited Works
- → The use of 19F spectroscopy and diffusion-weighted MRI to evaluate differences in gene-dependent enzyme prodrug therapies(2004)77 cited
- → Generation and comparison of CRISPR-Cas9 and Cre-mediated genetically engineered mouse models of sarcoma(2017)75 cited
- → Overcoming Preclinical Safety Obstacles to Discover (S)-N-((1,2,3,5,6,7-Hexahydro-s-indacen-4-yl)carbamoyl)-6-(methylamino)-6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazine-3-sulfonamide (GDC-2394): A Potent and Selective NLRP3 Inhibitor(2022)67 cited
- → Tumor genotype dictates radiosensitization after Atm deletion in primary brainstem glioma models(2020)41 cited
- → Genomic Status of MET Potentiates Sensitivity to MET and MEK Inhibition in NF1-Related Malignant Peripheral Nerve Sheath Tumors(2018)40 cited
- → Genetically engineered mouse models for studying radiation biology(2017)29 cited
- → Using Temporal Correlations and Full Distributions to Separate Intrinsic and Extrinsic Fluctuations in Biological Systems(2012)24 cited
- → The Fusion Oncogene FUS-CHOP Drives Sarcomagenesis of High-Grade Spindle Cell Sarcomas in Mice(2019)17 cited
- → Tumor Subtype Determines Therapeutic Response to Chimeric Polypeptide Nanoparticle–based Chemotherapy in Pten -deleted Mouse Models of Sarcoma(2020)9 cited
- → A source for low-background liquid scintillation detectors(1998)8 cited